Allan Lihme is an experienced commercial developer in the protein chemistry field.

While employed at the Protein Laboratory, University of Copenhagen he founded Kem-En-Tec A/S in 1982 with the aim of commercialising products within the field of protein analysis and protein isolation. In 1988 he became the Director of R&D and was the principal scientist in developing the technology for the spin-out of Upfront Chromatography A/S as well as Immunodex K/S and Amdex A/S in co-operation with Dako A/S.

Allan Lihme became the Managing Director as well as Director of R&D for Upfront Chromatography A/S in 1998. He has been non-executive board member in Immunodex K/S and Agroferm A/S and is presently a board member in Kem-En-Tec D&L A/S, Kem-En-Tec Diagnostics A/S, Kem-En-Tec Holding A/S and Upfront Chromatography A/S. Allan Lihme has an M.Sc. in biochemistry from the University of Copenhagen. He has 15 patent families and more than 10 commercially important scientific papers to his name.